Micro Medical this week announced that it received CE Mark approval for its long over-the-wire balloon catheter and MicroStent vascular stent. MicroStent and MicroBalloon XL are part of the company's MMS Micro Vascular Integrated Platform and are designed to achieve and maintain vessel latency and improve blood flow to reduce below-the-knee … [Read more...] about Micro Medical gains CE Mark for stent and balloon
Implants
Medtronic Resolute Onyx stent gains expanded FDA clearance
Medtronic today said it received FDA clearance for an expanded indication of its Resolute Onyx drug-eluting stent (DES). The new indication allows for one-month of dual-antiplatelet therapy (DAPT) labeling with an expanded indication for high bleeding risk patients that are implanted with the device. Resolute Onyx is the only DES in the U.S. … [Read more...] about Medtronic Resolute Onyx stent gains expanded FDA clearance
Teleflex wins FDA clearance for EZ-IO intraosseous vascular access system expanded indications
Teleflex today said it received FDA 510(k) clearance for expanded indications of its Arrow EZ-IO intraosseous vascular access system. The device is designed to be used when intravenous access is difficult or impossible to obtain in emergent, urgent or medically necessary cases. The expanded indication allows the device to be used for up to 48 … [Read more...] about Teleflex wins FDA clearance for EZ-IO intraosseous vascular access system expanded indications
W. L. Gore debuts lower-profile endoprosthesis
W.L. Gore this week announced it has launched its lower profile, large diameter Gore ViaBahn Endoprosthesis. The device design reduces the delivery profile for larger 9-13 mm diameter stent grafts by up to 3 Fr to enable delivery through smaller sheaths. The smaller introducer sheaths result in a lower risk of vascular access complications and … [Read more...] about W. L. Gore debuts lower-profile endoprosthesis
Study: Medtronic’s drug-coated balloon reduces dialysis interruptions
Medtronic (NYSE:MDT) recently announced the results of a study showing that some kidney disease patients who had a drug-coated balloon (DCB) implanted to treat arteriovenous (AV) failure experienced fewer interruptions of dialysis treatment. Many end-stage renal disease (ESRD) patients require AV fistulae in order to receive continuous dialysis. … [Read more...] about Study: Medtronic’s drug-coated balloon reduces dialysis interruptions
What is medical tubing used for?
Medical tubing allows clinicians to administer fluid and or even devices — as well as potentially allow for gas flow. And that's just the beginning. Common applications of medical tubing include ventilators and IVs, but tubing also finds uses supporting access devices and as a delivery method for other devices. For example, tubing can be used to … [Read more...] about What is medical tubing used for?
Abbott wins CE Mark for FlexNav delivery system
Abbott (NYSE:ABT) announced today that it won CE Mark approval in Europe for the FlexNav delivery system for its Portico transcatheter aortic valve implantation (TAVI) system. The Abbott Park, Ill.-based company’s FlexNav delivery system is designed to offer another tool for doctors to treat patients requiring a transcatheter aortic valve … [Read more...] about Abbott wins CE Mark for FlexNav delivery system
Medical tubing market to be worth $12 billion in 2025
The medical tubing market is expected to be worth $11.9 billion by 2025, according to an analysis from Grand View Research. Grand View Research suggests the industry will expand at a revenue-based consumer annual growth rate of 9.2% over the next five years. Increased health expenditures from individuals and increased emphasis on healthcare by … [Read more...] about Medical tubing market to be worth $12 billion in 2025
LivaNova pulls the plug on transcatheter mitral valve repair device
LivaNova (NSDQ:LIVN) said recently that it is ending its Caisson Interventional transcatheter mitral valve replacement (TMVR) program and plans to restructure its heart valve business to improve profitability. The company’s heart valve business represented nearly $130 million in revenue during fiscal 2018 and saw its revenue numbers decline over … [Read more...] about LivaNova pulls the plug on transcatheter mitral valve repair device
Study: Boston Sci’s Watchman cheaper than drugs long-term
A new study has found that use of the Boston Scientific (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device to treat atrial fibrillation costs less than existing and novel anticoagulant drugs over five years. The retrospective study pooled data from the randomized trials of the Marlborough, Mass.-based company’s Watchman device. The … [Read more...] about Study: Boston Sci’s Watchman cheaper than drugs long-term
